What is Abridge?
Abridge operates at the intersection of healthcare and machine learning, providing a sophisticated platform that records and transcribes medical appointments in real-time. By generating interactive, structured transcripts that highlight key clinical data, the company effectively reduces the administrative burden on healthcare providers while enhancing patient engagement and follow-through. The platform is designed to integrate seamlessly into both in-person and telemedicine workflows, ensuring that critical health information is captured accurately and made accessible to all stakeholders. As the industry shifts toward value-based care, Abridge's ability to synthesize complex medical conversations into actionable insights has positioned it as a vital tool for improving clinical outcomes and operational efficiency across the healthcare ecosystem.
How much funding has Abridge raised?
Abridge has raised a total of $757.5M across 6 funding rounds:
Other Financing Round
$15M
Series A
$12.5M
Series B
$30M
Series C
$150M
Series D
$250M
Series E
$300M
Other Financing Round (2020): $15M with participation from University of Pittsburgh Medical Center, Pillar, Bessemer Venture Partners, KdT Ventures, and Union Square Ventures
Series A (2022): $12.5M led by Bessemer Venture Partners, Wittington Ventures, and Union Square Ventures
Series B (2023): $30M supported by Spark Capital, Scan Group, LifePoint Health, Bessemer Venture Partners, Uc Investments, and Mayo Clinic
Series C (2024): $150M featuring Bessemer Venture Partners, Wittington Ventures, Lightspeed Venture Partners, Mass General Brigham, Redpoint Ventures, Union Square Ventures, Kaiser Permanente, and CVS Health
Series D (2025): $250M backed by CVS Health, California Health Care Foundation, Lightspeed Venture Partners, IVP, Elad Gil, CapitalG, and Bessemer Venture Partners
Series E (2025): $300M with participation from Lightspeed Venture Partners, CVS Health, and Andreessen Horowitz
Key Investors in Abridge
Bessemer Venture Partners
Bessemer Venture Partners is a global venture capital firm with a long history of supporting transformative technology companies from early stages through to maturity.
Lightspeed Venture Partners
Lightspeed Venture Partners is a global multistage venture capital firm that invests in early and growth-stage technology companies across sectors such as enterprise software and healthcare.
CVS Health
CVS Health is a leading healthcare organization focused on delivering superior, connected experiences and improving health outcomes through its extensive network of services.
What's next for Abridge?
With this latest infusion of capital, Abridge is well-positioned to accelerate its enterprise-level expansion and deepen its integration within large-scale health systems. The company's trajectory suggests a focus on scaling its AI-driven documentation capabilities to meet the growing demand for automated clinical workflows. By maintaining strong partnerships with major health networks and venture partners, Abridge is likely to prioritize the development of new features that further bridge the gap between patient-provider communication and electronic health record systems. As the company matures, its strategic roadmap will likely emphasize market penetration and the refinement of its proprietary models to ensure high-fidelity data capture in increasingly complex medical environments.
See full Abridge company page
